NCATS | Technology Transfer

Use of Epoxyketone Proteasome Inhibitors in the Treatment of Neuropathies Associated with Charcot-Marie-Tooth 1A (CMT1A) Disease

Read more about Use of Epoxyketone Proteasome Inhibitors in the Treatment of Neuropathies Associated with Charcot-Marie-Tooth 1A (CMT1A) Disease

US Application 61/702,297
Filed on 2012-09-18

The Use of Boronate Proteasome Inhibitors in the Treatment of Neuropathies Associated with Charcot-Marie-Tooth 1A (CMT1A) Disease

Read more about The Use of Boronate Proteasome Inhibitors in the Treatment of Neuropathies Associated with Charcot-Marie-Tooth 1A (CMT1A) Disease

US Application 61/702,295
Filed on 2012-09-18

A new chemical entity useful for treating various diseases

Read more about A new chemical entity useful for treating various diseases

US Application 61/710,505
Filed on 2012-10-05

Process For Synthesis Of Enantioenriched Aminoalcohols Containing A Tertiary Alcohol Fragment, And Derivatives Of Those Aminoalcohols Including The Co-crystal Of VT-1129 With Benzenesulfonic Acid (BSA).

Read more about Process For Synthesis Of Enantioenriched Aminoalcohols Containing A Tertiary Alcohol Fragment, And Derivatives Of Those Aminoalcohols Including The Co-crystal Of VT-1129 With Benzenesulfonic Acid (BSA).

US Application 61/801,784
Filed on 2013-03-15

Process For Synthesis Of Enantioenriched Aminoalcohols Containing A Tertiary Alcohol Fragment, And Derivatives Of Those Aminoalcohols Including The Co-crystal Of VT-1129 With Benzenesulfonic Acid (BSA).

Read more about Process For Synthesis Of Enantioenriched Aminoalcohols Containing A Tertiary Alcohol Fragment, And Derivatives Of Those Aminoalcohols Including The Co-crystal Of VT-1129 With Benzenesulfonic Acid (BSA).

US Application 61/802,393
Filed on 2013-03-16

Process For Synthesis Of Enantioenriched Aminoalcohols Containing A Tertiary Alcohol Fragment, And Derivatives Of Those Aminoalcohols Including The Co-crystal Of VT-1129 With Benzenesulfonic Acid (BSA).

Read more about Process For Synthesis Of Enantioenriched Aminoalcohols Containing A Tertiary Alcohol Fragment, And Derivatives Of Those Aminoalcohols Including The Co-crystal Of VT-1129 With Benzenesulfonic Acid (BSA).

US Application 61/802,217
Filed on 2013-03-15

Process For Synthesis Of Enantioenriched Aminoalcohols Containing A Tertiary Alcohol Fragment, And Derivatives Of Those Aminoalcohols Including The Co-crystal Of VT-1129 With Benzenesulfonic Acid (BSA).

Read more about Process For Synthesis Of Enantioenriched Aminoalcohols Containing A Tertiary Alcohol Fragment, And Derivatives Of Those Aminoalcohols Including The Co-crystal Of VT-1129 With Benzenesulfonic Acid (BSA).

US Application 61/802,071
Filed on 2013-03-15

Pyrazolo[1,5-a]pyrimidine Derivatives As Selective Inhibitors Of ALK Kinases For Inhibition Of The Bone Morphogenetic Proteins (BMP) Signaling Pathway

Read more about Pyrazolo[1,5-a]pyrimidine Derivatives As Selective Inhibitors Of ALK Kinases For Inhibition Of The Bone Morphogenetic Proteins (BMP) Signaling Pathway

US Application 61/783,695
Filed on 2013-03-14

NRF2 SMALL MOLECULE INHIBITORS FOR CANCER THERAPY

Read more about NRF2 SMALL MOLECULE INHIBITORS FOR CANCER THERAPY

US Application 61/798,843
Filed on 2013-03-15

Measurement of Cellular FMRP Levels for High Throughput Drug Screening and Diagnosis of Fragile X Syndrome

Read more about Measurement of Cellular FMRP Levels for High Throughput Drug Screening and Diagnosis of Fragile X Syndrome

US Application 61/793,577
Filed on 2013-03-15

Subscribe to NCATS